Skip to main content
Signal8

Immunovia AB (IMMVF)

Immunovia AB engages in the development of methods for diagnosing complex forms of cancer and autoimmune diseases. Its technology platform, IMMray, focuses on the early diagnosis of cancer, predicts disease progression, and monitors therapeutic responsiveness of cancers. The company was founded by Karl Arne Krister Borrebaeck on May 24, 2007 and is headquartered in Lund, Sweden.

Sector: Medical - Diagnostics & Research

Industry: Medical - Diagnostics & Research

Immunovia AB logo

Immunovia AB

OTC:IMMVFHealthcare
CLOSED
Mkt Cap-
EV-
Float654.34M
O/S672.67M
VOL1K sh
$ Vol$1
RVOL0.50×
Inst Own-
SI0.2%
Net Cash/Sh-
EarningsFeb 11 · in 3mo
Dilution